Immune-targeted therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Immune-targeted therapy, covering 2024-12-19 to 2024-12-19. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus [Phase 1]